Nu Skin Enterprises Inc. (NYSE:NUS) – Equities researchers at Jefferies Group lifted their FY2016 EPS estimates for Nu Skin Enterprises in a note issued to investors on Thursday. Jefferies Group analyst T. Young now expects that the firm will post earnings per share of $2.89 for the year, up from their previous forecast of $2.86. Jefferies Group has a “Hold” rating and a $61.00 price objective on the stock. Jefferies Group also issued estimates for Nu Skin Enterprises’ FY2017 earnings at $3.30 EPS.

Several other equities analysts have also issued reports on the company. Bank of America Corp. set a $56.00 target price on Nu Skin Enterprises and gave the company a “sell” rating in a report on Sunday, November 6th. Zacks Investment Research lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 27th. Citigroup Inc. upped their target price on Nu Skin Enterprises from $66.00 to $69.00 and gave the company a “buy” rating in a report on Wednesday, September 21st. TheStreet raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Thursday, August 4th. Finally, Deutsche Bank AG upped their target price on Nu Skin Enterprises from $55.00 to $57.00 and gave the company a “buy” rating in a report on Friday, August 5th. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $53.69.

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Nu Skin Enterprises (NYSE:NUS) opened at 52.60 on Monday. Nu Skin Enterprises has a 52 week low of $23.51 and a 52 week high of $66.04. The company has a market cap of $2.86 billion, a price-to-earnings ratio of 21.28 and a beta of 1.75. The stock has a 50 day moving average price of $61.75 and a 200 day moving average price of $52.17.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Thursday, November 3rd. The company reported $0.98 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.84 by $0.14. Nu Skin Enterprises had a return on equity of 20.06% and a net margin of 6.26%. The company had revenue of $604 million for the quarter, compared to analyst estimates of $583.74 million. During the same quarter last year, the company posted $0.71 EPS. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Friday, November 18th will be given a dividend of $0.355 per share. The ex-dividend date of this dividend is Wednesday, November 16th. This represents a $1.42 annualized dividend and a dividend yield of 2.70%. Nu Skin Enterprises’s dividend payout ratio is currently 57.96%.

In related news, Director Andrew D. Lipman sold 30,000 shares of the stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $64.13, for a total value of $1,923,900.00. Following the sale, the director now owns 36,090 shares in the company, valued at $2,314,451.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Steven Lund sold 61,000 shares of the stock in a transaction on Wednesday, October 26th. The stock was sold at an average price of $61.55, for a total value of $3,754,550.00. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Several large investors have recently modified their holdings of NUS. Washington Trust Bank increased its stake in shares of Nu Skin Enterprises by 0.6% in the third quarter. Washington Trust Bank now owns 2,011 shares of the company’s stock worth $130,000 after buying an additional 11 shares during the period. Solaris Asset Management LLC acquired a new stake in shares of Nu Skin Enterprises during the third quarter worth about $138,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Nu Skin Enterprises during the third quarter worth about $143,000. Metropolitan Life Insurance Co. NY increased its stake in shares of Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares during the period. Finally, Independent Portfolio Consultants Inc. acquired a new stake in shares of Nu Skin Enterprises during the third quarter worth about $157,000. Institutional investors own 77.11% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.